Skip to content

Jianda D. Yuan

Memorial Sloan Kettering Cancer Center

2 papers in the Anchorcite directory, published between 2014 and 2015, cited 12,267 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Alexandra Snyder · 2 papers
  • Vladimir Makarov · 2 papers
  • Phillip Wong · 2 papers
  • Teresa S. Ho · 2 papers
  • Cameron Bruggeman · 2 papers
  • Taha Merghoub · 2 papers
  • Jedd D. Wolchok · 2 papers
  • Timothy An-thy Chan · 2 papers

Papers

  1. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancerScience · 2015 · 7,918 citations

    Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are revolutionizing cancer treatment. To unravel the genomic determinants of response to this therapy, we used whole-exome sequencing of non-small cell lung cancers treated with pembrolizumab, an…

  2. Genetic Basis for Clinical Response to CTLA-4 Blockade in MelanomaNew England Journal of Medicine · 2014 · 4,349 citations

    BACKGROUND: Immune checkpoint inhibitors are effective cancer treatments, but molecular determinants of clinical benefit are unknown. Ipilimumab and tremelimumab are antibodies against cytotoxic T-lymphocyte antigen 4 (CTLA-4). Anti-CTLA-4 treatment prolongs overall survival in patients with melanoma. CTLA-4 blockade activates T…

Metadata from OpenAlex (CC0).